Innsbruck-Igls, Austria

Johann Jakob Leban


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Johann Jakob Leban: Innovator in Cyclin Dependent Kinase Inhibition

Introduction

Johann Jakob Leban, based in Innsbruck-Igls, Austria, is a notable inventor recognized for his significant contributions to medicinal chemistry. With a focus on developing pharmaceutical compositions aimed at treating cancer and other proliferative diseases, he has demonstrated a commitment to advancing healthcare through innovative research.

Latest Patents

Leban holds a patent for his invention titled "3-amino-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones as cyclin dependent kinase inhibitors." This groundbreaking work details the pharmaceutical applications of 3-amino-pyrazolo[3,4-d]pyrimidin-4-ones, specifically N-{4-[1-(2,6-dichloro-4-sulfamoyl-phenyl)-3-dimethylamino-4-oxo-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-ylmethyl]-phenyl}-2-diethylamino-acetamide, which serves as a potent inhibitor of cyclin dependent kinases. Moreover, his invention outlines the processes for synthesizing these compounds and their intermediates, playing a crucial role in cancer therapeutics.

Career Highlights

Throughout his career, Johann Jakob Leban has had the opportunity to work with prestigious institutions and companies. Notably, he has collaborated with the Medical University of Innsbruck and Vichem Chemie Kutató Korlátolt Felelősségű Társaság. His work in these establishments has enabled him to refine his research skills and contribute to significant advancements in the field of pharmacology.

Collaborations

Among his colleagues, Leban has worked closely with Winfried Wunderlech and Lukas A Huber. Their collective expertise has fostered a collaborative environment that has furthered the development of innovative pharmaceutical solutions and propelled advancements in cancer treatment.

Conclusion

Johann Jakob Leban's dedication to innovation and his pioneering work in cyclin dependent kinase inhibition have positioned him as an important figure in the pharmaceutical industry. His progress in developing effective treatments for cancer not only showcases his technical skills but also highlights the impact of his inventions on global health. As he continues to pursue research, the scientific community looks forward to his future contributions that may revolutionize treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…